Results 11 to 20 of about 10,143,944 (293)

Low Expression of FAM96B is Associated with Poor Prognosis in Hepatocellular Carcinoma

open access: yesThe Turkish Journal of Gastroenterology
Background/Aims: Recently, studies on FAM96B functions mainly focused on its role in maintaining the normal physiological function of cells. However, the clinical implications of FAM96B in hepatocellular carcinoma (HCC) are still unclear.
Yuqun Tang   +6 more
doaj   +4 more sources

Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma

open access: yesClinical, Cosmetic and Investigational Dermatology, 2023
Yanqiu Zhang, Yaling Li, Hongwei Yan Department of Dermatology, The First Hospital of China Medical University, Shenyang, 110001, People’s Republic of ChinaCorrespondence: Hongwei Yan, Department of Dermatology, The First Hospital of China Medical ...
Zhang Y, Li Y, Yan H
doaj   +3 more sources

Prognosis of Very Low-Birth Weight Infants

open access: yesPediatric Neurology Briefs, 1990
The cognitive and motor abilities of 43 very low birth weight children (VLBW) and classroom controls are reported from the Greenwood Children's Centre, City Hospital, Nottingham, England.
J Gordon Millichap
doaj   +4 more sources

Low BCL7A expression predicts poor prognosis in ovarian cancer

open access: yesJournal of Ovarian Research, 2019
Background and objective Ovarian cancer is a common gynaecological cancer with a poor prognosis that poses a serious threat to human life and health. It is essential to explore the possible prognostic biomarkers of ovarian cancer.
Ziqian Sun   +5 more
doaj   +2 more sources

Low STYK1 expression indicates poor prognosis in gastric cancer

open access: yesCancer Management and Research, 2018
Jian Fang,1,* Hao Wang,2,* Xiao Fang,3 Na Li,1 Hailiang Hu,1 Maohong Bian,1 Peng Yang1 1Department of Blood Transfusion, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China; 2Department of General Surgery and ...
Fang J   +6 more
doaj   +1 more source

A Novel Biomarker Driving Poor-Prognosis Liver Cancer: Overexpression of the Mitochondrial Calcium Gatekeepers

open access: yesBiomedicines, 2020
Several studies have indicated the biological role of mitochondrial Ca2+ uptake in cancer pathophysiology; however, its implications in predicting the prognosis of hepatocellular carcinoma (HCC) are not yet fully understood.
Chia-Jung Li   +4 more
doaj   +3 more sources

Low transthyretin is associated with the poor prognosis of colorectal cancer

open access: yesFrontiers in Oncology
ObjectiveTo determine whether transthyretin (TTR) influences the prognosis of patients with colorectal cancers and establish a predictive model based on TTR.MethodsBetween January 2013 and February 2019, the clinical data of 1322 CRC patients aged from ...
Zhe Zhang   +22 more
doaj   +3 more sources

The Prognosis of Low Back Pain in General Practice [PDF]

open access: yesSpine, 1997
A prospective cohort study on low back pain in consecutive patients in general practice, in which potential prognostic indicators at baseline and at the 1-year follow-up examination were assessed by means of four weekly questionnaires.To identify prognostic indicators of the duration of low back pain in general practice and the occurrence of a relapse ...
van den Hoogen, H.J.M.   +4 more
openaire   +3 more sources

HER2-Low Breast Cancer: Molecular Characteristics and Prognosis [PDF]

open access: yesCancers, 2021
Background: We aimed to determine the distribution of intrinsic subtypes within HER2-low breast cancer (BC), and to describe the prognostic impact of HER2-low status on survival outcomes. Methods: This is a retrospective, observational study of primary BC extracted from The Cancer Genome Atlas dataset.
Elisa Agostinetto   +7 more
openaire   +3 more sources

Cumulative live birth rates in low-prognosis women. [PDF]

open access: yesHum Reprod, 2019
Do cumulative live birth rates (CLBRs) over multiple IVF/ICSI cycles confirm the low prognosis in women stratified according to the POSEIDON criteria?The CLBR of low-prognosis women is ~56% over 18 months of IVF/ICSI treatment and varies between the POSEIDON groups, which is primarily attributable to the impact of female age.The POSEIDON group recently
Leijdekkers JA   +15 more
europepmc   +6 more sources

Home - About - Disclaimer - Privacy